Bumper Offer - Urjas oil Just @ Rs. 1
Olipar Plus is an allopathic medicine The correct dosage of Olipar Plus depends on the patient's age, gender, and medical history. This information has been provided in detail in the dosage section.
Olipar Plus is used to treat the following -
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
| Age Group | Dosage |
| 13 - 18 years (Adolescent) |
|
| Adult |
|
| Geriatric |
|
Based on research, the following side effects have been observed when Olipar Plus is used -
Moderate
Mild
Is the use of Olipar Plus safe for pregnant women?
Olipar Plus may cause moderate side effects during pregnancy. If you feel its harmful effects, then stop taking this drug immediately, and do not take Olipar Plus again without your doctor's advice.
Is the use of Olipar Plus safe during breastfeeding?
Olipar Plus may cause serious side effects in breastfeeding women, so do not take this drug without doctor's advice.
What is the effect of Olipar Plus on the Kidneys?
Olipar Plus does not damage the kidneys.
What is the effect of Olipar Plus on the Liver?
Olipar Plus is rarely harmful for the liver.
What is the effect of Olipar Plus on the Heart?
Olipar Plus is rarely harmful for the heart.
Olipar Plus should not be taken with following medicines due to severe side effects it may cause to patients -
Severe
Moderate
If you are suffering from any of the following diseases, you should not take Olipar Plus unless your doctor advises you to do so -
Is this Olipar Plus habit forming or addictive?
No, there is no any evidence that Olipar Plus is addictive.
Interaction between Food and Olipar Plus
Olipar Plus may take longer to act if you eat some foods while taking it. Follow your doctor's advice on this.
Interaction between Alcohol and Olipar Plus
Taking alcohol with Olipar Plus can be dangerous.
Olipar Plus is available in the forms tablet, capsule, suspension, and syrup. It should be taken exactly as recommended by your doctor. It may be taken with or without food because food does not affect the absorption of the drug. It is important to take Olipar Plus at the same time every day so that you do not forget to take the dose. Olipar Plus may take 4 to 5 weeks to exert its complete effect and it is thus, important to be patient and keep taking Olipar Plus.
Yes, Olipar Plus can cause weight loss. It is a common side effect of this drug. Few people may experience this effect after consuming this drug. People should monitor their weight, eat healthily and include at least 30 mins of exercising in a day. In spite of all efforts if you experience weight loss then discuss with your doctor.
Olipar Plus should be taken as long as it prescribed by your doctor. One must not take less or number of doses as that could cause detrimental effects on the health. One should follow the instructions of the doctor completely.
Yes, Olipar Plus may affect one's sex life by decreasing one's libido. However, if you experience sex life is affected after medicine then inform your doctor immediately they might change your medication or altered the dose.
No, it is not recommended that you discontinue taking Olipar Plus on your own as this may cause certain withdrawal symptoms like agitation, irritation, mood changes, and difficulty falling or staying asleep. It is, therefore, suggested that you follow the instructions of your doctor completely and remain compliant to the treatment plan.
This medicine data has been created by -
B.Pharma, Pharmacy
7 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Prozac (fluoxetine hydrochloride)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 458,461
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 588-591
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 932-934
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 442
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Zyprexa (olanzapine)
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Zyprexa Intramuscular (olanzapine)
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Zyprexa Relprevv (olanzapine)